Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [709]
News [2443]
Articles [199]
Editorials [6]
Conferences [89]
elearning [31]
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study...
ASCO 2025: Pro-inflammatory diets associated with worse outcomes for stage III colon cancer
ASCO 2025: Pro-inflammatory diets associated with worse outcomes for stage III colon cancer
ASCO 2025: Atezolizumab chemo combo leads to improved survival in deficient mismatch repair colon cancer
ASCO 2025: Atezolizumab chemo combo leads to improved survival in deficient mismatch repair colon cancer
ASCO 2025: Exercise programme may lower risk of recurrence and death for some colon cancer survivors
ASCO 2025: Exercise programme may lower risk of recurrence and death for some colon cancer survivors
ASCO 2025: Perioperative treatment with durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers
ASCO 2025: Perioperative treatment with durvalumab and FLOT chemo can reduce risk of recurrence for some gastric...
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
ASCO 2025: GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for people with diabetes
ASCO 2025: GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for people with...
ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer
ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients...
Gut bacteria may hold key to unlocking better cancer treatment
Gut bacteria may hold key to unlocking better cancer treatment
ASCO 2025: Alcohol-fueled cancer deaths are on the rise in the US
ASCO 2025: Alcohol-fueled cancer deaths are on the rise in the US

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation